
Bristol Myers Squibb discloses results from it's Phase I Breakfree-2 trial of CAR-T therapy zola-cel for multiple sclerosis.
Ashfield Engage, a business unit of Ashfield, part of UDG Healthcare, has formed the Ashfield Excellence Academy to design, develop, and deliver specialist training, skills assessments and process consultancy to the healthcare and pharma industries.
Previously known as ”Ashfield Insight & Performance,” the training agency has grown and enhanced its capabilities across three specialist divisions:






